Litcius/Paper detail

Genomics to select treatment for patients with metastatic breast cancer

Fabrice André, Thomas Filleron, Maud Kamal, Fernanda Mosele, Mónica Arnedos, Florence Dalenc, Marie‐Paule Sablin, Mario Campone, Hervé Bonnefoi, Claudia Lefeuvre‐Plesse, William Jacot, Florence Coussy, Jean-­Marc Ferrero, George Emile, Marie‐Ange Mouret‐Reynier, Jean‐Christophe Théry, Nicolás Isambert, Alice Mège, Philippe Barthélémy, Benoît You, Nawale Hajjaji, Ludovic Lacroix, Etienne Rouleau, Alicia Tran-Dien, Sandrine Boyault, Valéry Attignon, Pierre Gestraud, Nicolas Servant, Christophe Le Tourneau, Linda Larbi Chérif, Isabelle Soubeyran, Filippo Montemurro, Alain Morel, Amélie Lusque, Marta Jimenez, Alexandra Jacquet, Anthony Gonçalvès, Thomas Bachelot, Ivan Bièche

2022Nature168 citationsDOI

Topics & Concepts

MedicineBreast cancerMetastatic breast cancerInternal medicineOncologyCancerGenomicsGermlineConfidence intervalOlaparibHazard ratioTargeted therapyBioinformaticsGenomeGeneticsGeneBiologyPoly ADP ribose polymerasePolymeraseCancer Genomics and DiagnosticsPARP inhibition in cancer therapyAdvanced Breast Cancer Therapies